145 related articles for article (PubMed ID: 1601521)
1. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer.
Vitolo D; Zerbe T; Kanbour A; Dahl C; Herberman RB; Whiteside TL
Int J Cancer; 1992 Jun; 51(4):573-80. PubMed ID: 1601521
[TBL] [Abstract][Full Text] [Related]
2. In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment.
Vitolo D; Kanbour A; Johnson JT; Herberman RB; Whiteside TL
Eur J Cancer; 1993; 29A(3):371-7. PubMed ID: 8398338
[TBL] [Abstract][Full Text] [Related]
3. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas.
Merogi AJ; Marrogi AJ; Ramesh R; Robinson WR; Fermin CD; Freeman SM
Hum Pathol; 1997 Mar; 28(3):321-31. PubMed ID: 9042797
[TBL] [Abstract][Full Text] [Related]
4. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.
Barth RJ; Camp BJ; Martuscello TA; Dain BJ; Memoli VA
Cancer; 1996 Sep; 78(6):1168-78. PubMed ID: 8826937
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of cytokine mRNA expression in tumour-infiltrating mononuclear cells and tumour cells freshly isolated from human colorectal carcinomas.
Csiszár A; Szentes T; Haraszti B; Zou W; Emilie D; Petrányi G; Pócsik E
Eur Cytokine Netw; 2001 Mar; 12(1):87-96. PubMed ID: 11282551
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the activation status of tumor infiltrating and peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate.
Elsässer-Beile U; Przytulski B; Gierschner D; Grussenmeyer T; Katzenwadel A; Leiber C; Deckart A; Wetterauer U
Prostate; 2000 Sep; 45(1):1-7. PubMed ID: 10960837
[TBL] [Abstract][Full Text] [Related]
7. Lack of IL-2 cytokine expression despite Il-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers.
Coventry BJ; Weeks SC; Heckford SE; Sykes PJ; Bradley J; Skinner JM
J Immunol; 1996 May; 156(9):3486-92. PubMed ID: 8617977
[TBL] [Abstract][Full Text] [Related]
8. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocytes and peripheral-blood lymphocytes from patients with breast cancer.
Rubbert A; Manger B; Lang N; Kalden JR; Platzer E
Int J Cancer; 1991 Aug; 49(1):25-31. PubMed ID: 1908441
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of interleukin-2 and CD3 triggering on cytokine gene transcription and secretion in cultured tumor infiltrating lymphocytes.
Filgueira L; Zuber M; Juretic A; Lüscher U; Caetano V; Harder F; Garotta G; Heberer M; Spagnoli GC
Cell Immunol; 1993 Aug; 150(1):205-18. PubMed ID: 8343966
[TBL] [Abstract][Full Text] [Related]
11. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes.
Wang Q; Redovan C; Tubbs R; Olencki T; Klein E; Kudoh S; Finke J; Bukowski RM
Int J Cancer; 1995 Jun; 61(6):780-5. PubMed ID: 7790111
[TBL] [Abstract][Full Text] [Related]
12. Immunologic effector cells in head and neck cancer.
Vitolo D; Letessier EM; Johnson JT; Whiteside TL
J Natl Cancer Inst Monogr; 1992; (13):203-8. PubMed ID: 1356393
[TBL] [Abstract][Full Text] [Related]
13. Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer.
Barton DP; Blanchard DK; Wells AF; Nicosia SV; Roberts WS; Cavanagh D; Djeu JY
Anticancer Res; 1994; 14(3A):761-72. PubMed ID: 8074478
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes.
Maeurer MJ; Walter W; Martin D; Zitvogel L; Elder E; Storkus W; Lotze MT
Scand J Immunol; 1997 Feb; 45(2):182-92. PubMed ID: 9042431
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
[TBL] [Abstract][Full Text] [Related]
16. High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma.
Roussel E; Gingras MC; Grimm EA; Roth JA
Cancer Immunol Immunother; 1995 Jul; 41(1):1-9. PubMed ID: 7641214
[TBL] [Abstract][Full Text] [Related]
17. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
Stoppacciaro A; Forni G; Colombo MP
Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
[TBL] [Abstract][Full Text] [Related]
18. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes.
Camp BJ; Dyhrman ST; Memoli VA; Mott LA; Barth RJ
Ann Surg Oncol; 1996 Mar; 3(2):176-84. PubMed ID: 8646519
[TBL] [Abstract][Full Text] [Related]
19. Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours.
Schöndorf T; Engel H; Lindemann C; Kolhagen H; von Rücker AA; Mallmann P
Cancer Immunol Immunother; 1997 Apr; 44(2):88-96. PubMed ID: 9177470
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]